{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:20:17Z","timestamp":1790911217330,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajt.2025.08.019","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:19:20Z","timestamp":1757096360000},"page":"322-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evolving landscape of thrombotic microangiopathy in kidney transplant recipients in the post\u2013C5 inhibitor era"],"prefix":"10.1016","volume":"26","author":[{"given":"L\u00e9o","family":"Drapeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Paraire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-1196","authenticated-orcid":false,"given":"Mehdi","family":"Maanaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7403-4607","authenticated-orcid":false,"given":"Viviane","family":"Gnemmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Prov\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6317-9763","authenticated-orcid":false,"given":"R\u00e9mi","family":"Lenain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-2164","authenticated-orcid":false,"given":"Christophe","family":"Masset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5033-1228","authenticated-orcid":false,"given":"Christine","family":"Kandel-Aznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1487-5743","authenticated-orcid":false,"given":"Clarisse","family":"Kerleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9505-2718","authenticated-orcid":false,"given":"Karine","family":"Autain-Renaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-8002","authenticated-orcid":false,"given":"Fadi","family":"Fakhouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7461-8298","authenticated-orcid":false,"given":"Marie","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-6187","authenticated-orcid":false,"given":"Simon","family":"Ville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajt.2025.08.019_bib1","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/j.1600-6143.2011.03686.x","article-title":"Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes","volume":"11","author":"Tonelli","year":"2011","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.08.019_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1432-2277.2006.00354.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"19","author":"Ponticelli","year":"2006","journal-title":"Transpl Int"},{"issue":"7","key":"10.1016\/j.ajt.2025.08.019_bib3","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2025.08.019_bib4","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.transproceed.2012.07.039","article-title":"De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival","volume":"44","author":"Caires","year":"2012","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.ajt.2025.08.019_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5500\/wjt.v8.i5.122","article-title":"Thrombotic microangiopathy after renal transplantation: current insights in de novo and recurrent disease","volume":"8","author":"Abbas","year":"2018","journal-title":"World J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.08.019_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trre.2017.10.001","article-title":"De novo thrombotic microangiopathy after kidney transplantation","volume":"32","author":"Garg","year":"2018","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.ajt.2025.08.019_bib7","article-title":"Thrombotic microangiopathy after kidney transplantation: an underdiagnosed and potentially reversible entity","volume":"8","author":"\u00c1vila","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.ajt.2025.08.019_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.6002\/ect.2021.0069","article-title":"De novo and recurrent thrombotic microangiopathy after renal transplantation: current concepts in management","volume":"20","author":"Abbas","year":"2022","journal-title":"Exp Clin Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2025.08.019_bib9","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States","volume":"42","author":"Reynolds","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajt.2025.08.019_bib10","article-title":"Thrombotic microangiopathy in the renal allograft: results of the TMA Banff Working Group consensus on pathologic diagnostic criteria","volume":"36","author":"Afrouzian","year":"2023","journal-title":"Transpl Int"},{"issue":"7","key":"10.1016\/j.ajt.2025.08.019_bib11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ajt.2025.08.019_bib12","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic\u2013uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"issue":"10095","key":"10.1016\/j.ajt.2025.08.019_bib13","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.ajt.2025.08.019_bib14","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.kint.2019.01.023","article-title":"Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors","volume":"95","author":"Le Clech","year":"2019","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ajt.2025.08.019_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.ajkd.2022.10.014","article-title":"Renal thrombotic microangiopathy: a review","volume":"81","author":"Genest","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.ajt.2025.08.019_bib16","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1600-6143.2010.03178.x","article-title":"De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection","volume":"10","author":"Satoskar","year":"2010","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2025.08.019_bib17","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/tri.12331","article-title":"An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies","volume":"27","author":"Sreedharanunni","year":"2014","journal-title":"Transpl Int"},{"issue":"suppl 1","key":"10.1016\/j.ajt.2025.08.019_bib18","first-page":"131","article-title":"De novo thrombotic microangiopathy in renal transplant patients","volume":"16","author":"\u00d6zdemir","year":"2018","journal-title":"Exp Clin Transplant"},{"issue":"11","key":"10.1016\/j.ajt.2025.08.019_bib19","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/nrneph.2012.212","article-title":"The role of complement in antibody-mediated rejection in kidney transplantation","volume":"8","author":"Stegall","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.ajt.2025.08.019_bib20","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.4049\/jimmunol.1501686","article-title":"The complement system and antibody-mediated transplant rejection","volume":"195","author":"Stites","year":"2015","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.ajt.2025.08.019_bib21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/MOT.0000000000000216","article-title":"Effects of complement activation on allograft injury","volume":"20","author":"Sheen","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2025.08.019_bib22","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","article-title":"Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation","volume":"8","author":"Le Quintrec","year":"2008","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.08.019_bib23","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1681\/ASN.V641160","article-title":"Recurrent hemolytic uremic syndrome in an adult renal allograft recipient: current concepts and management","volume":"6","author":"Agarwal","year":"1995","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ajt.2025.08.019_bib24","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","article-title":"Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation","volume":"12","author":"Zuber","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2025.08.019_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.12659\/AOT.908491","article-title":"Effect of preformed or de novo anti-HLA antibodies on function and graft survival in kidney transplant recipients","volume":"23","author":"de Sousa","year":"2018","journal-title":"Ann Transplant"},{"issue":"2","key":"10.1016\/j.ajt.2025.08.019_bib26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"Sellar\u00e9s","year":"2012","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.08.019_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10157-012-0635-1","article-title":"Luminex and antibody detection in kidney transplantation","volume":"16","author":"Picascia","year":"2012","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"10.1016\/j.ajt.2025.08.019_bib28","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1681\/ASN.2012111064","article-title":"Cyclosporine induces endothelial cell release of complement-activating microparticles","volume":"24","author":"Renner","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ajt.2025.08.019_bib29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0272-6386(96)90468-0","article-title":"Cyclosporine-associated thrombotic microangiopathy\/hemolytic uremic syndrome following kidney and kidney-pancreas transplantation","volume":"28","author":"Young","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.ajt.2025.08.019_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00007890-199902270-00009","article-title":"FK506-associated thrombotic microangiopathy: report of two cases and review of the literature","volume":"67","author":"Trimarchi","year":"1999","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ajt.2025.08.019_bib31","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1046\/j.1523-1755.1999.00492.x","article-title":"Cyclosporine-associated thrombotic microangiopathy in renal allografts","volume":"55","author":"Zarifian","year":"1999","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ajt.2025.08.019_bib32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ajt.2025.08.019_bib33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1600-6143.2004.00428.x","article-title":"Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin\u2013sirolimus combination","volume":"4","author":"Fortin","year":"2004","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.08.019_bib34","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","article-title":"Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys","volume":"5","author":"Sartelet","year":"2005","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2025.08.019_bib35","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.transproceed.2014.07.062","article-title":"Everolimus, cyclosporine, and thrombotic microangiopathy: clinical role and preventive tools in renal transplantation","volume":"46","author":"Nava","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ajt.2025.08.019_bib36","series-title":"Clinical database associated with a biological banking accessible to initiate epidemiological and translational collaborative researches in kidney transplantation (DIVAT). ClinicalTrials.gov identifier: NCT02900040","year":"2016"},{"issue":"1","key":"10.1016\/j.ajt.2025.08.019_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.kint.2022.09.030","article-title":"A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection","volume":"103","author":"Haas","year":"2023","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.ajt.2025.08.019_bib38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ajt.2024.01.029","article-title":"De novo thrombotic microangiopathy after kidney transplantation in adults: interplay between complement genetics and multiple endothelial injury","volume":"24","author":"Dessaix","year":"2024","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.ajt.2025.08.019_bib39","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2019040331","article-title":"Use of highly individualized complement blockade has revolutionized clinical outcomes after kidney transplantation and renal epidemiology of atypical hemolytic uremic syndrome","volume":"30","author":"Zuber","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ajt.2025.08.019_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/j.ajkd.2022.12.020","article-title":"C3 glomerulopathy with concurrent thrombotic microangiopathy: clinical and immunological features","volume":"82","author":"Chabannes","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.ajt.2025.08.019_bib41","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.kint.2019.08.024","article-title":"Shiga toxin\u2013producing Escherichia coli\u2013associated hemolytic uremic syndrome in solid organ transplant recipients","volume":"96","author":"Ville","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajt.2025.08.019_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.718122","article-title":"Histopathologic features of antibody mediated rejection: the Banff classification and beyond","volume":"12","author":"Cornell","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.ajt.2025.08.019_bib43","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1681\/ASN.2018070777","article-title":"Archetype analysis identifies distinct profiles in renal transplant recipients with transplant glomerulopathy associated with allograft survival","volume":"30","author":"Aubert","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ajt.2025.08.019_bib44","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.08.019_bib45","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ajt.2025.08.019_bib46","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.kint.2024.02.014","article-title":"Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies","volume":"105","author":"Maisons","year":"2024","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.ajt.2025.08.019_bib47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ekir.2024.01.013","article-title":"\u201cEculizumab First\u201d in the management of posttransplant thrombotic microangiopathy","volume":"9","author":"Maritati","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.ajt.2025.08.019_bib48","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-6143.2008.02482.x","article-title":"Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy","volume":"9","author":"Ashman","year":"2009","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.ajt.2025.08.019_bib49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/ctr.12170","article-title":"Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients","volume":"27","author":"Koppula","year":"2013","journal-title":"Clin Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525029338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525029338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:35:16Z","timestamp":1778621716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525029338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1600613525029338"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.08.019","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving landscape of thrombotic microangiopathy in kidney transplant recipients in the post\u2013C5 inhibitor era","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}